Catalent Inc (NYSE:CTLT)
$ 58.48 -0.21 (-0.36%) Market Cap: 10.61 Bil Enterprise Value: 15.28 Bil PE Ratio: 0 PB Ratio: 2.94 GF Score: 79/100

Catalent Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 10:15PM GMT
Release Date Price: $46.66 (+2.03%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Hello everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team here at JPMorgan. I'm pleased to introduce the Catalent management team. As we typically have done with most of these sessions, this will be a roughly 20-minute presentation followed by 20 minutes of Q&A. And with that, I will hand it off to Alessandro.

Alessandro Maselli
Catalent, Inc. - President, CEO & Director

Thank you. Hello, everyone. Good afternoon. Welcome to our presentation. I'm very excited to be here. And before I get started, I want to share a short story yesterday when I stepped into the conference, I had one of those flashbacks, thinking about being here 12 months ago, 12 months -- the last 12 months and this flashback of what happened in the last 12 months and was quite a lot, right?

It was surely an eventful period for the industry event for Catalent but one in which we also made several progresses and we had also some exciting stuff happening. So hopefully

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot